SCHEMBL23174993

SCHEMBL23174993

NC(=O)Oc1ccc(CBr)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
KIF11 P52732 1/20 0.46
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
ELANE P08246 1/20 0.40
PARP10 Q53GL7 1/20 0.40
PRSS1 P07477 2/20 0.38
F2 P00734 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38
THRB P10828 1/20 0.37
TMPRSS2 O15393 1/20 0.36
KLK1 P06870 1/20 0.36
TRPA1 O75762 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28842285 0.84 KMT2A (0.44) MEN1KMT2AKIF11ELANEPARP10
SCHEMBL9542970 0.83 ELANE (0.57) MEN1KMT2AKIF11ELANEPARP10
SCHEMBL6284986 0.82 KMT2A (0.64) MEN1KMT2AKIF11ELANEPARP10
SCHEMBL13650268 0.81 MEN1 (0.48) MEN1KMT2AKIF11ELANEPARP10
SCHEMBL11052300 0.80 KIF11 (0.47) MEN1KMT2AKIF11ELANEPARP10
SCHEMBL11610897 0.79 CES2 (0.42) MEN1KMT2ACES2CES1ELANE
SCHEMBL5562888 0.79 MEN1 (0.47) MEN1KMT2AKIF11ELANEPARP10
SCHEMBL1835776 0.79 RAB9A (0.53) MEN1KMT2AKIF11ELANETHRB
SCHEMBL868628 0.79 LMNA (0.57) MEN1KMT2AELANEALDH1A1
SCHEMBL11375700 0.78 PRSS1 (0.56) MEN1KMT2AKIF11PRSS1TMPRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111936468-B Compounds with anticancer activity 协和麒麟株式会社 2024-03-08 CN disclosed
WO-2023236960-A1 CARBOXAMIDE DERIVATIVE HAVING RSK INHIBITORY EFFECT, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF 上海科恩泰生物医药科技有限公司 2023-12-14 WO disclosed
CN-117186098-A Carboxamide derivative with RSK inhibition effect, pharmaceutical composition containing carboxamide derivative and application of carboxamide derivative 上海科恩泰生物医药科技有限公司 2023-12-08 CN disclosed
WO-2023198195-A1 CONJUGATE COMPRISING TOLL-LIKE RECEPTOR AGONIST MABSOFT THERAPEUTICS (SHANGHAI) CO., LTD. (CN) 2023-10-19 WO disclosed
CN-114845996-B Benzene ring-containing compound and application thereof 武汉朗来科技发展有限公司 2023-09-12 CN disclosed
WO-2023109954-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF LYNK PHARMACEUTICALS CO. LTD. (CN) 2023-06-22 WO disclosed
WO-2023109120-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF LYNK PHARMACEUTICALS CO. LTD. (CN) 2023-06-22 WO disclosed
WO-2023108536-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF LYNK PHARMACEUTICALS CO. LTD. (CN) 2023-06-22 WO disclosed
CN-114845996-A Compound containing benzene ring and application thereof 武汉朗来科技发展有限公司 2022-08-02 CN disclosed
CN-109563043-B Substituted pyridines as inhibitors of DNMT1 葛兰素史密斯克莱知识产权发展有限公司 2022-05-31 CN disclosed
CN-114502534-A BET degradant 协和麒麟株式会社 2022-05-13 CN disclosed
CN-113620950-A Carboxamide derivatives useful as RSK inhibitors 凤凰分子设计公司 2021-11-09 CN disclosed
CN-109071542-B Carboxamide derivatives useful as RSK inhibitors 凤凰分子设计公司 2021-07-20 CN disclosed
WO-2021065980-A1 BET DEGRADER 協和キリン株式会社 2021-04-08 WO disclosed
CN-111936468-A Compounds with anti-cancer activity 协和麒麟株式会社 2020-11-13 CN disclosed
CN-109071542-A CARBOXAMIDE DERIVATIVES USEFUL AS RSK INHIBITORS 凤凰分子设计公司 2018-12-21 CN disclosed